JSA, SAM act on Avendus acquiring ₹300 crore stake in Aragen Life Sciences

Avendus Future Leaders Fund III (Avendus) has acquired a stake in Aragen Life Sciences Limited from Reddy Investment Trust for ₹300 crore, through a secondary purchase.

The secondary round also involved investment into Aragan by SBI Life Insurance Company Limited, which acquired a stake in Aragen from Reddy Investment Trust.

JSA Advocates & Solicitors advised Avendus on this stake acquisition

The transaction team consisted of Sidharrth Shankar (Partner), Prakriti Jaiswal (Partner), Rishika Agarwal (Senior Associate), Eksha Narayan (Senior Associate) and Mahi Jaiswal (Associate).

Shardul Amarchand Mangaldas & Co advised Reddy Investment Trust on the sale of shares to Aragen and SBI.

The transaction team consisted of Karun Prakash (Partner), Sangamitra Sankaraiah (Partner) and Hitakshi Mahendru (Senior Associate).

Aragen Life Sciences is one of India's leading fully integrated contract research, development and manufacturing organizations (CRDMOs) providing contract services across the cycle of drug development (discovery to commercial manufacture) for both small molecules and biologics.

If you would like your Deals, Columns, Press Releases to be published on Bar & Bench, please fill in the form available here.